Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Orlistat (Xenical, Hoffmann LaRoche) in African American and Caucasian Children and Adolescents With Obesity-Related Comorbid Conditions

NCT00001723 is registered in ClinicalTrials.gov with Jack Yanovski as lead sponsor.

NCT NCT00001723
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00001723 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Orlistat (Xenical, Hoffmann LaRoche) in African American and Caucasian Children and Adolescents With Obesity-Related Comorbid Conditions
Lead sponsor
Jack Yanovski
Phase
Phase 2
Overall status
Completed
Start date
May 31, 1998
Completion date
October 31, 2011
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, hypertension, metabolic disease, obesity, sleep apnea syndrome